Theravance Biopharma, Inc. (TBPH) Revenue by Year
Theravance Biopharma, Inc. generated $107.5M in revenue in fiscal year 2025. This represents an increase of 66.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $104.3M in revenue. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Theravance Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TBPH Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $104.3M | $107.5M+66.9% | $64.4M+12.1% | $57.4M+11.8% | $51.3M-7.2% | $55.3M-23.0% | $71.9M-2.1% | $73.4M+21.6% | $60.4M+292.4% | $15.4M-68.4% | $48.6M+15.5% | $42.1M+260.4% | $11.7M+5071.7% | $226K-99.8% | $130.1M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
TBPH Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Theravance Biopharma, Inc. financials
Frequently Asked Questions
What was Theravance Biopharma, Inc.'s revenue in fiscal year 2025?
Theravance Biopharma, Inc. generated $107.5M in revenue in fiscal year 2025.
How fast is Theravance Biopharma, Inc.'s revenue growing?
Theravance Biopharma, Inc. (TBPH) revenue rose by 66.9% year over year, from $64.4M to $107.5M in fiscal year 2025.
What is Theravance Biopharma, Inc.'s revenue over the last twelve months?
Theravance Biopharma, Inc. (TBPH) reported $104.3M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Theravance Biopharma, Inc.'s revenue changed over the years?
Across the 14 fiscal years this page covers, Theravance Biopharma, Inc. (TBPH) revenue went from $130.1M in fiscal year 2012 to $107.5M in fiscal year 2025.
What was Theravance Biopharma, Inc.'s revenue in the most recent quarter?
Theravance Biopharma, Inc. (TBPH) reported $20.7M in revenue in Q2 2026. This represents a decrease of 20.9% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Theravance Biopharma, Inc. (TBPH) reported on that line in every period on record.